Cashu
Corvus Pharmaceuticals Advances CPI-818 in Promising Immuno-Oncology Research and Clinical Trials
3 months ago
Stocks
Health Care
crvs
Corvus Pharmaceuticals
NASDAQ: CRVS
+12.12 (+150.56%)
20.17
USD
At close at Jan 20, 21:40 UTC
Latest Corvus Pharmaceuticals News
benzinga.com
Earnings Scheduled For November 4, 2025
3 months ago
benzinga.com
Why Is Corvus Pharmaceuticals Stock Soaring On Friday?
9 months ago
businesswire.com
Kaskela Law LLC Announces Shareholder Investigation of Corvus Pharmaceuticals, Inc. (NASDAQ: CRVS) and Encourages Investors to Contact the Firm
over 1 year ago
businesswire.com
Kaskela Law LLC Announces Shareholder Investigation of Corvus Pharmaceuticals, Inc. (NASDAQ: CRVS) and Encourages Investors to Contact the Firm
over 1 year ago
finance.yahoo.com
Corvus Pharmaceuticals to Present at the H.C. Wainwright 26th Annual Global Investment Conference
over 1 year ago
finance.yahoo.com
Corvus: Q2 Earnings Snapshot
over 1 year ago
finance.yahoo.com
Corvus Pharmaceuticals Granted FDA Fast Track Designation for Soquelitinib for Treatment of Patients with Relapsed or Refractory Peripheral T-cell Lymphoma (PTCL)
over 1 year ago
finance.yahoo.com
Corvus Pharmaceuticals to Provide Business Update and Second Quarter 2024 Financial Results on August 6, 2024
over 1 year ago
finance.yahoo.com
Publication of Preclinical Data in Science Signaling Demonstrated the Potential of ITK Inhibition with Soquelitinib as a Novel Approach to Treatment of Inflammatory Diseases
over 1 year ago
finance.yahoo.com
T cell Lymphoma Therapeutics Research 2024: Comprehensive Insights about 90+ Companies and 90+ Pipeline Drugs
over 1 year ago
Join our newsletter to keep up to date with us!
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.